Q: Can I get your view on the earnings release?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello, Can you please comment on the results?..Dividends increased but stocks hit pretty badly..Thanks
Q: Pason seems to fly under the radar...what do you think of Q4?
Q: What do you think of JWEL's latest Fourth Quarter and full year 2018 results - would you buy at these levels. I bought it when it first went public - like the China exposure and the recent partnership with atop pharmacy chain in India - also their quality control is known for being very high as well - was thinking of adding more at these prices.
Q: Afternoon guys:
What do you folks think of this story.
Thx mark
What do you folks think of this story.
Thx mark
Q: Thoughts on the quarter?
Q: Can you comment on Thomson Reuters quarter and guidance for next year Thank You
Q: I saw you response on their earnings.Stock gets slammed and now is right back up. Do i sell it? what about a switch maybe cigi Colliers
Q: I've done very well with SHOP (thanks to 5i) but it has grown to 12% of my overall portfolio. I really like to let the winners run, and am quite risk tolerant, however I am considering selling 20% and reinvesting the proceeds. I plan to top up KXS, which seems has good momentum, but need some other suggestions. What other technology stocks would you suggest at this time? Options outside of tech would be appreciated too.
Q: Hello Peter,
I like your response from the previous question on Canntrust but I would appreciate it if you can provide comments as to why this company which has been touted by analysts and BNN guests as one of the better players in the cannibis space, yet it has performed poorly when compared to most of the mid and large cap players. When you look at the chart from inception to now, Canntrust has not done well. Their fundamentals and strategy appear to be sound but why such a gap (comparing to weed, acb, cron, hexo, ogi, etc).
Also, on another note, KSHB, Kush holdings is bascially a picks and shovels play in the US for cannibis packaging etc and only trades over the counter (not on your list). It plans to list on nasdaq or nyse. If this happens, what would happen to my shares if they were bought over the counter. Would i be able to sell same shares on nyse or nasdaq. Apppreciate it.
I like your response from the previous question on Canntrust but I would appreciate it if you can provide comments as to why this company which has been touted by analysts and BNN guests as one of the better players in the cannibis space, yet it has performed poorly when compared to most of the mid and large cap players. When you look at the chart from inception to now, Canntrust has not done well. Their fundamentals and strategy appear to be sound but why such a gap (comparing to weed, acb, cron, hexo, ogi, etc).
Also, on another note, KSHB, Kush holdings is bascially a picks and shovels play in the US for cannibis packaging etc and only trades over the counter (not on your list). It plans to list on nasdaq or nyse. If this happens, what would happen to my shares if they were bought over the counter. Would i be able to sell same shares on nyse or nasdaq. Apppreciate it.
Q: Wonder if you recommend any stocks in this field and even if you don't which is more buyable by someone who wants to buy regardless?
Q: hi 5i team,
As a follow on to Joseph's question re high ROE companies (asked on February 22, 2019)...can you comment on Cott Corp (BCB) (was in the list of companies) recent results and on the company overall? I ask as their ROE number is 38 which seems pretty good. How are their other financial metrics?
Would you consider this now a growth company (given last years asset sales) or simply an income oriented company?
If you were to rate it, would it be a 'B' type company?
Thanks!
Steve
As a follow on to Joseph's question re high ROE companies (asked on February 22, 2019)...can you comment on Cott Corp (BCB) (was in the list of companies) recent results and on the company overall? I ask as their ROE number is 38 which seems pretty good. How are their other financial metrics?
Would you consider this now a growth company (given last years asset sales) or simply an income oriented company?
If you were to rate it, would it be a 'B' type company?
Thanks!
Steve
Q: any thoughts on Planet 13 as long term hold
Q: hello team, this stock is approaching 10 year low, keeping in mind current political storm, this company has no future? do you see value in the company?
Thanks for taking my question
Thanks for taking my question
Q: As a holder of aw I am consernd about your comments that the beef used is antibiotic free .
The use of growth hormones in the beef industry is all but redundant due to the advancement on genitics.there for a easy thing to say and advertise.
Antibiotic free beef is something that is impossible on a commercial scale and AW on there website verified this .
In 5:i assessment of aw claimed it sells only antibiotic free meat not so
Kind regards
Stan
The use of growth hormones in the beef industry is all but redundant due to the advancement on genitics.there for a easy thing to say and advertise.
Antibiotic free beef is something that is impossible on a commercial scale and AW on there website verified this .
In 5:i assessment of aw claimed it sells only antibiotic free meat not so
Kind regards
Stan
Q: Hi All,
Do you have some thoughts on FLWR:CA
Thanks.
John
Do you have some thoughts on FLWR:CA
Thanks.
John
Q: I'd would like to know which faster-growing companies are NOT missing numbers and you're comfortable with ?
Q: Could you please comment on TTD's earnings release.
Thank you for your wonderful service.
Peter
Thank you for your wonderful service.
Peter
Q: Hello
I believe Finning has now reported. May I have your comments please. Is this a keeper? Thank you
I believe Finning has now reported. May I have your comments please. Is this a keeper? Thank you
Q: I have made very good returns in 2018 on Canopy Growth and HMMJ and have since sold all positions. I am considering a base position totaling 3 to 5% for a long term hold. As clarity evolves over long term performance I can adjust my holdings. How would you rank the three names given or would it be most prudent to diversify across all three initially?